Visser + Ophtalmo
ActiveFrom the official registers: KBO 3 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Visser + Ophtalmo has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€517,778) and a net result of -€165,396. Equity has been shrinking by about 58% per year since 2023. Its solvency ranks better than 5% of 3,024 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Overview
Official details
KBO- Status
- Active since 24-04-2023 Normal situation
- Activity
- Nutrition and dietetics services NACE 86995
- Establishment unit
- 2.344.881.067 9700 Oudenaarde, since 24-04-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 06-05-2026
Board and ownership
- OPHTALMO VISION CAREDirector · permanent representative DE KEUKELEERE Jean-Charles
- Visser Contactlenzen BelgiëDirector · permanent representative FRANSEN Franciscus Johannes Maria
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.4%
- Gross margin
- €88,439
- Turnover
- ≈ €250,000
- estimated
- Loss
- €165,396
- ▼ 31.5%
- Equity
- -€517,778
- ▼ 46.9%
- Total assets
- €198,262
- ▼ 9.4%
- Staff
- 2.5 FTE
- =
Score breakdownraises riskCapped at 59: negative equityNegative equity -€517,778Loss of €165,396, the second in a row (financial year 2025)lowers riskSector: Human health activities (NACE 86)Founded in 2023Show the evidence
Checked score
About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 1% of them on solvency, 4% on liquidity, 1% on profitability and 13% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 3 accounts on average 16 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Key points
- Risk: Negative equitydebts exceed assets in financial year 2025 -€517,778 View
- Risk: 3 loss-making years in a rowloss in financial year 2025 -€165,396 View
- Caution: Lower solvency than 95% of companies in human healthsector median 59.1% · 3,024 companies -261.2% View
- Caution: Equity fell in 2025from -€352,382 to -€517,778 ▼ 46.9% View
Comparable companies
These companies have the same main activity as Visser + Ophtalmo: nutrition and dietetics services (NACE 86995). They are comparable in size and age: total assets between €169,000 and €623,000, founded between 2022 and 2024.
| Company | Total assets | Gross margin |
|---|---|---|
| Visser + Ophtalmo Oudenaarde | €198,262 | €88,439 |
| WALLONIE AUDITION Braine-le-Comte | €179,187 | €185,683 |
| SPOTWATCH Aalter | €622,819 | €87,187 |
| ORAL HEALTH CARE Lievegem | €176,430 | €74,946 |
| Amelaur Gent | €193,630 | €81,951 |
| ER-ASSIST Berlare | €168,679 | €61,671 |
| V VERSTRAETEN RA SUPPORT Wetteren | €264,458 | €126,565 |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 17-07-2026
- Annual accounts 2024filed on 02-07-2025
- Annual accounts 2023filed on 31-10-2024
Acts in the Belgian Official Gazette
- Incorporationact of 26-04-2023
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about Visser + Ophtalmo
- What is the company number of Visser + Ophtalmo?
- The company number of Visser + Ophtalmo is 0801.066.580. The VAT number is the same number with BE in front: BE 0801.066.580.
- Where is Visser + Ophtalmo based?
- The registered office is at Industriepark "De Bruwaan" 5, 9700 Oudenaarde.Company details
- What does Visser + Ophtalmo do?
- According to the KBO register, the main activity is nutrition and dietetics services (NACE 86995).
- What is the legal form of Visser + Ophtalmo?
- The legal form of Visser + Ophtalmo is Private limited company (BV).
- When was Visser + Ophtalmo founded?
- Visser + Ophtalmo was founded on 24-04-2023.
- Is Visser + Ophtalmo still active?
- Yes, Visser + Ophtalmo is an active enterprise in the KBO register.
- How many employees does Visser + Ophtalmo have?
- Visser + Ophtalmo had an average of 2.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of Visser + Ophtalmo?
- The turnover in financial year 2025 is ≈ €250,000. This figure is estimated from the gross margin of €88,439 and 34 comparable companies (NACE 869). It probably lies between €160,000 and €400,000.
- Is Visser + Ophtalmo profitable?
- In financial year 2025, Visser + Ophtalmo made a loss of €165,396.
- Where can I find the annual accounts of Visser + Ophtalmo?
- Visser + Ophtalmo filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of Visser + Ophtalmo due?
- Visser + Ophtalmo must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.